Additionally, Luo et al. believed that the expression of CDKN2A may help to regulate tumor-related macrophages, dendritic cells, and T cells and that CDKN2A may play an important role in immune infiltrating cells and also can be used as one of the prognostic biomarkers of HCC patients [55]. The gene discussed is CDKN2A; the disease is neoplasm.